Td Asset Management Inc Agenus Inc Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$3.17 - $4.49 $201,612 - $285,564
-63,600 Closed
0 $0
Q3 2020

Nov 10, 2020
SELL
$2.98 - $5.2 $98,936 - $172,640
-33,200 Reduced 34.3%
63,600 $254,000
Q2 2020

Aug 13, 2020
BUY
$2.29 - $4.24 $221,672 - $410,432
96,800 New
96,800 $380,000

Others Institutions Holding AGEN

# of Institutions
8
Shares Held
2.07M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email